HC Wainwright Brokers Reduce Earnings Estimates for Edap Tms

Key Points

• HC Wainwright has lowered its FY2029 earnings per share (EPS) estimates for EDAP TMS to $0.20, down from $0.31, while the current consensus estimate stands at ($0.60) per share.
• While some analysts have issued a "hold" rating, the stock's average rating remains "hold," with a target price of $8.50.
• Institutional investors own nearly 62.74% of EDAP TMS's shares, indicating significant interest from large investment firms.

Edap Tms S.A. (NASDAQ:EDAP - Free Report) - Equities research analysts at HC Wainwright dropped their FY2029 earnings per share (EPS) estimates for shares of Edap Tms in a research note issued on Friday, August 29th. HC Wainwright analyst S. Ramakanth now expects that the medical equipment provider will post earnings of $0.20 per share for the year, down from their prior estimate of $0.31. The consensus estimate for Edap Tms' current full-year earnings is ($0.60) per share.

A number of other research firms have also issued reports on EDAP. Piper Sandler lowered Edap Tms from an "overweight" rating to a "neutral" rating in a research note on Thursday, May 15th. Wall Street Zen initiated coverage on Edap Tms in a research note on Thursday, May 15th. They set a "hold" rating on the stock. One analyst has rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $8.50.

Edap Tms Price Performance

Shares of NASDAQ:EDAP remained flat at $2.52 during midday trading on Monday. The company had a trading volume of 134,627 shares, compared to its average volume of 171,560. The company has a quick ratio of 1.05, a current ratio of 1.51 and a debt-to-equity ratio of 0.04. Edap Tms has a 12 month low of $1.21 and a 12 month high of $3.29. The company has a market capitalization of $94.23 million, a price-to-earnings ratio of -4.13 and a beta of -0.21. The business's 50 day moving average price is $1.58 and its two-hundred day moving average price is $1.84.

Hedge Funds Weigh In On Edap Tms

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Banque Transatlantique SA grew its position in Edap Tms by 7,063.7% during the first quarter. Banque Transatlantique SA now owns 730,699 shares of the medical equipment provider's stock worth $1,324,000 after buying an additional 720,499 shares in the last quarter. Scoggin Management LP purchased a new position in Edap Tms during the first quarter worth about $686,000. Schonfeld Strategic Advisors LLC grew its position in Edap Tms by 48.5% during the fourth quarter. Schonfeld Strategic Advisors LLC now owns 160,800 shares of the medical equipment provider's stock worth $355,000 after buying an additional 52,500 shares in the last quarter. Sage Mountain Advisors LLC purchased a new position in Edap Tms during the second quarter worth about $165,000. Finally, Cetera Investment Advisers grew its position in Edap Tms by 33.9% during the first quarter. Cetera Investment Advisers now owns 75,000 shares of the medical equipment provider's stock worth $147,000 after buying an additional 19,000 shares in the last quarter. 62.74% of the stock is currently owned by hedge funds and other institutional investors.

About Edap Tms

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.